SPL 0.00% $2.10 starpharma holdings limited

Astrazeneca's forward decisions

  1. 2,728 Posts.
    lightbulb Created with Sketch. 130
    AB appreciate your opinion re, AZ have two candidates running, SPL's in house tests heading into phase two, lab tests on another oncology drug show's great result, so AZ is now looking at treatments outside the current licence agreement, how do they deal with this, re-negotiate current licence? set up a new agreement?or what?. Is it getting close to the point that AZ start to think that they want to own this DEP technology? If they do believe that the SPL DEP technology is the best thing since sliced bread will they want to be going drug to drug with licence payments leaving SPL to deal with others as well or do they say NO we need to stitch this up now. Then what do they pay??
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Mkt cap ! $852.6M
Open High Low Value Volume
$2.25 $2.25 $2.08 $1.802M 849.5K

Buyers (Bids)

No. Vol. Price($)
1 2392 $2.09

Sellers (Offers)

Price($) Vol. No.
$2.12 4886 2
View Market Depth
Last trade - 16.10pm 03/03/2021 (20 minute delay) ?
0.000 ( 0.52 %)
Open High Low Volume
$2.20 $2.20 $2.08 207315
Last updated 15.59pm 03/03/2021 (live) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.